Talar Lesions…Allograft No Better Than Microfracture?
Orthopedics This Week highlighted a recent study by HSS foot and ankle surgeon Mark C. Drakos, MD, who investigated the effectiveness of a new allograft technology in treating cartilage injuries.
Dr. Drakos told OTW, "cartilage injuries continue to be challenging issues to treat for orthopedic surgeons. The current treatment of microfracture (MF) has several shortcomings including mixed long-term outcomes. We were looking to improve upon the current standard of care by using some of the newer allograft technologies."
According to the article, Dr. Drakos and his colleagues compared the results of patients treated with microfracture versus patients treated with DeNovo NT for juvenile allogenic chondrocyte implantation (ACI) with autologous bone marrow aspirate (BMAC).
"The most important results were that there was no difference in either clinical outcome or radiographic appearance between using the juvenile particulate cartilage allograft and the conventional microfracture technique," he explained.
Read the full article at ryortho.com [subscription required].